B014

B014 Suppliers list
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Shanghai Yu Ben Biotechnology Co., Ltd.  
Tel: 021-61350663 15502154572
Email: 1639466865@qq.com
Company Name: Shanghai Hongye Biotechnology Co. Ltd  
Tel: 400-9205774 400-920-5774
Email: sales@glpbio.cn

B014 manufacturers

  • MPT0B014
  • MPT0B014 pictures
  • $48.00
  • 2026-04-22
  • CAS:1215208-59-5
  • Purity: 99.56%
  • Supply Ability: 10g
B014 Basic information
Product Name:B014
Synonyms:6-Quinolinyl(3,4,5-trimethoxyphenyl)methanone;B014;MPT0B014;MPT0B014 >=98% (HPLC);Methanone, 6-quinolinyl(3,4,5-trimethoxyphenyl)-;PARP-2-IN-3;MPT0B014, 10 mM in DMSO;Quinolin-6-yl(3,4,5-trimethoxyphenyl)methanone
CAS:1215208-59-5
MF:C19H17NO4
MW:323.34
EINECS:
Product Categories:
Mol File:1215208-59-5.mol
B014 Structure
B014 Chemical Properties
Boiling point 513.5±50.0 °C(Predicted)
density 1.211±0.06 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: soluble5mg/mL, clear (warmed)
form powder
pka3.84±0.10(Predicted)
color white to beige
Safety Information
Hazard Codes T
Risk Statements 25
Safety Statements 45
RIDADR UN 2811 6.1 / PGIII
WGK Germany 3
MSDS Information
B014 Usage And Synthesis
UsesMPT0B014 is a tubulin polymerization inhibitor. MPT0B014 induces cancer cell apoptosis. MPT0B014 can be used for the research of cancer[1].
in vivo

The combination of MPT0B014 (100 mg/kg; i.v./i.p.; daily for 25 days) and 25 mg/kg Erlotinib (HY-50896) significantly improves A549 tumor inhibition in mice[1].

Animal Model:Nude athymic mice, A549 xenografts[1]
Dosage:100 mg/kg alone or in combination with 25 mg/kg Erlotinib (HY-50896)
Administration:i.v./i.p., daily for 25 days
Result:The combined treatment resulted in more significant tumor growth delay (28%) compared with treatment alone (7%). The combination produced significantly higher anti-tumor activity. The growth of A549 cancer cell xenografts was suppressed by 11, 21 and 49% (tumor growth inhibition) after treatment with MPT0B014, Erlotinib and MPT0B014 plus Erlotinib, respectively.
References[1] Tsai AC, et al. In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells. Br J Pharmacol. 2014 Jan;171(1):122-33. DOI:10.1111/bph.12427
B014 Preparation Products And Raw materials
Tag:B014(1215208-59-5) Related Product Information
4-(4-Propoxybenzoyl)quinoline 3-(3,4-Dimethoxybenzoyl)quinoline 3-(4-Phenoxybenzoyl)quinoline TGF-beta RI Kinase Inhibitor VII 4-(3,4-Dimethoxybenzoyl)isoquinoline B014